Trading Analysis Report: APH
- Analysis date: 2026-05-29
- Processed decision: Buy
- Price Target: $182
I. Analyst Team Reports
Market Analyst
Market Analyst
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $148.76 | Entry price for the rating and target. |
| Market capitalization | $183.01B | Amphenol is a large-cap interconnect and sensor platform. |
| Enterprise value | $197.29B | Debt-adjusted value captures the recent acquisition program. |
| 52-week range | $88.77-$167.04 | Shares are near the upper end of the annual range. |
| 50-day / 200-day averages | $135.85 / $133.61 | Price is above both trend lines, showing positive momentum. |
| Forward P/E | 26.40x | The market is pricing above-average earnings growth. |
| Trailing P/E | 42.75x | Reported earnings multiple is elevated after rapid share appreciation. |
| Price/sales | 7.06x | Revenue multiple is premium and needs sustained growth. |
| EV/revenue | 7.62x | Enterprise valuation is high for an industrial technology supplier. |
| EV/EBITDA | 24.14x | EBITDA valuation leaves limited room for execution mistakes. |
| Dividend yield | 0.67% | The thesis is growth and capital appreciation, not income. |
| Analyst mean / median target | $182.00 / $180.00 | Consensus implies meaningful upside from the close. |
| Analyst high / low target | $215.00 / $135.00 | Dispersion shows upside potential but also valuation risk. |
| Q1 2026 sales | $7.6B, +58% | The latest quarter showed exceptional reported growth. |
| Q1 2026 organic sales growth | +33% | Growth was not only acquisition-driven. |
| Q1 2026 orders | $9.4B | Demand exceeded revenue, supporting backlog momentum. |
| Q1 2026 book-to-bill | 1.24:1 | Orders materially exceeded sales in the quarter. |
| Q1 2026 adjusted EPS | $1.06, +68% | Earnings growth outpaced sales growth. |
| Q1 2026 adjusted operating margin | 27.3% | Margin remains strong despite integration activity. |
| Q2 2026 sales outlook | $8.1B-$8.2B | Management guided to another step up in revenue. |
| FY2025 sales / organic growth | $23.1B / +38% | 2025 established a much higher revenue base. |
| FY2025 adjusted EPS | $3.34, +77% | Per-share earnings compounded sharply in 2025. |
| FY2025 free cash flow | $4.4B | Cash generation supports acquisitions and capital returns. |
APH closed at $148.76 on May 29, 2026, above both the 50-day and 200-day moving averages. The stock has strong momentum, but it is still below the analyst mean target of $182 and median target of $180.
The market setup supports a Buy because growth is unusually strong. Q1 2026 sales grew 58% to $7.6 billion, organic sales grew 33%, orders reached $9.4 billion, and book-to-bill was 1.24:1. The Q2 sales outlook of $8.1 billion to $8.2 billion implies the growth cycle remains active.
The caveat is valuation. Forward P/E of 26.40x, price/sales of 7.06x, and EV/EBITDA of 24.14x are premium levels. A $182 target, near the analyst mean target, is appropriate because the business is executing well but the share price already discounts a lot of good news.
Sentiment Analyst
Sentiment Analyst
Sentiment is constructive. Amphenol reported record first quarter 2026 results, with sales, orders, adjusted EPS, and adjusted operating margin all showing strong momentum. Investors received a clear demand signal from the 1.24:1 book-to-bill ratio, which indicates that orders substantially exceeded quarterly sales.
The narrative is especially strong in IT datacom and high-speed interconnects. Management attributed Q1 growth to strong organic demand across most end markets, exceptional organic growth in IT datacom, and contributions from acquisitions. The CommScope CCS acquisition also expands Amphenol's exposure to connectivity and cable infrastructure.
Sentiment risk is tied to how much has already been priced in. Shares are close to their 52-week high, and valuation multiples are high. If orders normalize or acquisition integration slows margin progress, the premium multiple could compress. Still, the current combination of growth, margin quality, and consensus target upside supports a Buy.
News Analyst
News Analyst
The key news item is Amphenol's first quarter 2026 results, released on April 29, 2026. Sales were $7.6 billion, up 58% in U.S. dollars and 33% organically compared with the first quarter of 2025. Orders were $9.4 billion, producing a 1.24:1 book-to-bill ratio.
Profitability was strong. GAAP diluted EPS was $0.72, up 24%, and adjusted diluted EPS was $1.06, up 68%. GAAP operating margin was 24.0%, adjusted operating margin was 27.3%, operating cash flow was $1.1 billion, and free cash flow was $831 million.
Management guided Q2 2026 sales to $8.1 billion to $8.2 billion and adjusted diluted EPS to $1.14 to $1.16. The latest full-year release showed 2025 sales of $23.1 billion, adjusted diluted EPS of $3.34, adjusted operating margin of 26.2%, operating cash flow of $5.4 billion, and free cash flow of $4.4 billion.
Sources: Amphenol Q1 2026 results release dated April 29, 2026; Amphenol Q4 and full-year 2025 results release dated January 28, 2026; market snapshot retrieved May 31, 2026 for the May 29, 2026 NYSE close.
Fundamentals Analyst
Fundamentals Analyst
Amphenol's fundamentals are excellent. Q1 2026 sales grew 58% to $7.6 billion, organic sales grew 33%, adjusted EPS grew 68% to $1.06, and adjusted operating margin reached 27.3%. The quarter showed both end-market demand and operating leverage.
Cash generation is a core strength. The company produced $1.1 billion of operating cash flow and $831 million of free cash flow in Q1 2026. In 2025, operating cash flow was $5.4 billion and free cash flow was $4.4 billion. That cash flow supports acquisition integration, dividends, share repurchases, and balance-sheet flexibility.
The balance sheet and valuation need monitoring. The market snapshot shows total debt of about $18.75 billion and cash of about $4.58 billion. Debt increased in importance after the CommScope CCS acquisition, which was expected to add about $4.1 billion of 2026 sales and about $0.15 of adjusted diluted EPS. The acquisition can create value, but execution now matters.
Valuation is premium but defensible. APH trades at 26.40x forward earnings and 7.06x sales, while growth, order momentum, and margins are well above typical industrial levels. The fundamentals support Buy with a disciplined $182 target.
II. Research Team Decision
Bull Researcher
Bull Case
The bull case is that Amphenol is one of the clearest beneficiaries of rising electronics complexity, AI data center connectivity, defense electronics, aerospace, industrial automation, and communications infrastructure. Q1 2026 organic sales growth of 33% and orders of $9.4 billion show demand strength beyond acquisitions.
Margins make the growth higher quality. Adjusted operating margin was 27.3% in Q1, and adjusted EPS grew 68%, faster than sales. This suggests that the company is converting growth into earnings rather than simply buying revenue.
The $182 target is reasonable because it sits near the analyst mean target and below the high target of $215. If Amphenol sustains high order intake and integrates CommScope CCS effectively, upside can continue despite a premium multiple.
Bear Researcher
Bear Case
The bear case is valuation and execution risk. APH is near its 52-week high and trades at 26.40x forward earnings, 7.06x sales, and 24.14x EV/EBITDA. Those multiples require continued order strength, margin discipline, and successful integration.
Acquisition complexity is also higher. The CommScope CCS acquisition increases scale but also raises debt, integration, working-capital, and synergy execution risk. If integration costs are higher than expected or if customers slow orders after the initial demand surge, the market could reduce the multiple.
End markets can be cyclical. Automotive, mobile devices, communications networks, and industrial demand can weaken quickly. A book-to-bill ratio of 1.24:1 is strong, but if it normalizes, investors may question whether the current valuation is sustainable.
Research Manager
Research Manager Decision
The research decision is Buy with a $182 price target. Amphenol combines unusually strong organic growth, record orders, high adjusted margins, robust cash generation, and consensus target upside.
The target is disciplined. A $182 target is aligned with the analyst mean target of $182.00 and only modestly above the median target of $180.00. It reflects about 22% upside from the May 29 close while recognizing that valuation is already premium.
Price Target: $182
Rating: Buy.
III. Trading Team Plan
Trader
Trader Plan
APH can be accumulated on pullbacks and held toward the $182 target. The stock is above its 50-day and 200-day averages, so momentum is positive, but the price is also near the 52-week high. A staged entry is better than chasing a single print.
Risk controls should focus on Q2 sales delivery against the $8.1 billion to $8.2 billion guide, adjusted operating margin around the high-20% range, order growth, CommScope CCS integration, and debt reduction. If book-to-bill falls sharply below 1.0 or margins compress materially, the target should be revisited.
Upside confirmation would come from continued IT datacom strength, durable defense and aerospace demand, and evidence that acquisitions are adding earnings without diluting margin quality.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk Analyst
The aggressive view supports buying. Amphenol is showing rare growth for a large industrial technology company: Q1 sales up 58%, organic sales up 33%, adjusted EPS up 68%, and orders above sales. This is the type of momentum that can sustain a premium multiple.
The company also has strong cash flow and a long acquisition track record. If CommScope CCS adds scale and earnings as expected, the market can keep rewarding APH as a high-quality compounder.
Conservative Analyst
Conservative Risk Analyst
The conservative view is to size the position carefully. The stock is not cheap, and the market snapshot shows elevated valuation across forward earnings, sales, and EBITDA. A lot of strength is already reflected in the share price.
Debt and integration risk also matter. Total debt is about $18.75 billion, and the company is absorbing a large connectivity acquisition. Conservative investors should use staged entries and avoid assuming that Q1's 33% organic growth can continue indefinitely.
Neutral Analyst
Neutral Risk Analyst
The balanced view is Buy with valuation discipline. The operating evidence is strong enough to justify upside: record sales, record orders, high adjusted operating margin, and a Q2 guide above Q1 sales.
The offset is that APH is a premium stock. A $182 target is appropriate because it follows consensus fair value rather than assuming an aggressive rerating. The key monitoring points are order conversion, CommScope CCS integration, adjusted margin, free cash flow, and debt.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Final decision: Buy.
Price Target: $182
APH is suitable for investors seeking high-quality exposure to AI infrastructure, interconnects, sensors, aerospace, defense, industrial, and communications demand. Q1 2026 sales grew 58% to $7.6 billion, organic sales grew 33%, orders reached $9.4 billion, adjusted EPS grew 68% to $1.06, and adjusted operating margin reached 27.3%.
The stock closed at $148.76, above both key moving averages but still below the analyst mean target of $182. The target implies roughly 22% upside and is supported by management's Q2 2026 sales outlook of $8.1 billion to $8.2 billion.
The main risks are premium valuation, debt, acquisition integration, and cyclical end-market demand. These risks argue for staged accumulation, but the current growth, margin, order, and target-spread profile supports Buy.